Salute e Benessere

Philips Visual Patient Avatar pioneers at-a-glance patient data for faster…

Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errorsAmsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Visual Patient Avatar , a revolutionary new monitoring solution that translates critical, yet complex patient data into a straightforward visual design as an easy-to-understand avatar display. In today's...
Nasdaq GlobeNewswire
13/10/2023

E-Clinical Solutions Market size worth USD 17.6 Billion, Globally, by 2030 at…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=2029 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=2029 Browse in-depth TOCon" E-Clinical Solutions Market " 202 - Pages 126 – Tables 37 – Figures E-Clinical Solutions Market: Revolutionizing Clinical Trials with Advanced Technologies In a dynamic landscape where the pursuit of medical breakthroughs is relentless, E-Clinical solutions are emerging...
PR Newswire
13/10/2023

Healthcare BPO Market size worth USD 747.81 Billion, Globally, by 2028 at 10.61%…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=1961 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=1961 Browse in-depth TOCon" Healthcare BPO Market " 202 - Pages 126 – Tables 37 – Figures Global Healthcare BPO Market: Transforming Healthcare Delivery Through Strategic Outsourcing The healthcare landscape is undergoing a paradigm shift with the advent of Healthcare Business Process...
PR Newswire
13/10/2023

Immunoassay Market Worth $46.7 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 Browse in-depth TOC on "Immunoassay Market" 307 - Tables 54 - Figures 394 - Pages Immunoassay Market Scope: The reagents & kits accounted for the largest share of the immunoassay market, by product segment, in 2022. The global immunoassay market is segmented into...
PR Newswire
13/10/2023

Press Release: Late-breaking amlitelimab Phase 2b data presented at EADV show…

Late-breaking amlitelimab Phase 2b data presented at EADV show potential best-in-class profile in atopic dermatitisPatients treated with amlitelimab experienced up to 61.5% improvement in average Eczema Area and Severity Index (EASI) score from baseline at week 16, the primary endpoint, with continued improvement seen through 24 weeksClinically meaningful improvements were seen in all key secondary endpoints at week 16 with continued improvements through week 24, including for IGA 0/1...
Nasdaq GlobeNewswire
13/10/2023

Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of…

The Company and its consultants are working intensively to finalize this last key section of the MAA, after overcoming an unexpected delay in that regard. The Company strongly believes that after so many years of work on the DCVax-L program, taking some additional time to help ensure that the full MAA package is as strong as it can be is especially important since the Company plans to submit applications to multiple regulators. The Company and its consultants are working intensively to...
PR Newswire
13/10/2023

Late-breaking data for Roche's BTK inhibitor fenebrutinib show brain penetration…

New data from Phase II FENopta study in relapsing multiple sclerosis (RMS) show fenebrutinib crosses the blood-brain barrier with the potential to act directly on the chronic inflammation related to multiple sclerosis (MS) More than 90% relative reduction in new/enlarging T2 lesions and new T1 gadolinium-enhancing (Gd+) lesions with fenebrutinib beginning at 8 weeks The safety profile of fenebrutinib was consistent with previous and ongoing clinical trials across more than 2,500...
Nasdaq GlobeNewswire
13/10/2023

Managers' Transactions

October 13, 2023 - Announcement No. 10 Vesting of sharesChr. Hansen Holding A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in Chr. Hansen Holding A/S made by persons discharging managerial responsibilities in Chr. Hansen Holding A/S and/or persons closely related with them.Please see attachment.For further information please contact: Anders Mohr Christensen, Vice President Group Strategy &...
Nasdaq GlobeNewswire
13/10/2023

New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year…

A lot of the main efforts in fighting this particular cancer are in line with the work of the Pancreatic Cancer Action Network (PanCAN). They've been asking supporters from every state in the US to get in touch with Congress to boost federal funds for pancreatic cancer research. A lot of the main efforts in fighting this particular cancer are in line with the work of thePancreatic Cancer Action Network (PanCAN). They've been askingsupporters from every statein the US to get in touch with...
PR Newswire
13/10/2023

Novo Nordisk raises sales and operating profit outlook for 2023

Bagsværd, Denmark, 13 October 2023 –Novo Nordisk today announced that the sales and operating profit growth at constant exchange rates (CER) for the first nine months of 2023 and that the full-year sales and operating profit outlook at CER have been raised.In the first nine months of 2023, Novo Nordisk's sales increased by 33% and operating profit increased by 37% both at CER. Profit and loss (CER)Third quarter 2023First nine months 2023 Sales growth38%33%Operating...
Nasdaq GlobeNewswire
13/10/2023

Tiziana Announces Positive Qualitative Six-Month PET Scan Results With…

Five out of six patients in FDA authorized Expanded Access Program are showing a qualitative reduction in microglia activation (a key biomarker being observed)Foralumab to advance into Phase 2 human clinical trials using the world's only fully human intranasal anti-CD3 monoclonal antibodyPhase 2 trial screening for na-SPMS to begin in November 2023NEW YORK, Oct.13, 2023(GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq:TLSA ) (“Tiziana” or the “Company”), a biotechnology...
Nasdaq GlobeNewswire
13/10/2023

Smart Healthcare Products Market Poised for Exponential Growth, Projected to…

The contemporary, health-conscious society is witnessing an upsurge in consumer demand for health management tools. Patients and individuals are actively seeking ways to take charge of their health, and smart healthcare products are answering this call by offering advanced tools for health monitoring and management. Additionally, the global aging population is translating to an increased requirement for healthcare services and products that can effectively manage chronic conditions, monitor…
PR Newswire
13/10/2023

Healthcare Analytics Market Soars: Infinium Global Research's Latest Report…

The global healthcare analytics market has been experiencing unprecedented growth, underpinned by the surge in healthcare data, including Electronic Health Records (EHRs), medical imaging, patient-generated data, and genomic information. This influx of data serves as a significant driver for market expansion. Additionally, regulatory compliance, such as the Meaningful Use program in the United States, mandates the adoption of EHR systems and data analytics, further propelling market growth…
PR Newswire
13/10/2023

PCI Biotech initiates field testing of its proprietary technology for gene…

The partners have signed a collaborative research agreement with the purpose of testing PCI Biotech's proprietary technology for gene therapy manufacturing in the partners' pilot manufacturing process. PCI Biotech brings its novel and promising technology for viral vector manufacturing into the field testing, while the partner provides facilities and expertise, as well as feedback on performance and usability of the technology, to guide PCI Biotech's future development. The research...
Nasdaq GlobeNewswire
13/10/2023

World Thrombosis Day encourages public to "Move Against Thrombosis" to celebrate…

Thrombosis can develop in, or travel to, blood vessels throughout the body, often causing symptoms that can be mistaken for other conditions. The most common signs of a blood clot in the leg, or deep vein thrombosis (DVT), can include tenderness in the calf, swelling of the ankle or foot, redness and/or warmth in the area. Signs of a blood clot in the lungs, or pulmonary embolism (PE), can include unexplained shortness of breath, rapid breathing, chest pain, rapid heart rate and/or…
PR Newswire
13/10/2023

Alimentiv Inc. Announces New Scientific Advisors Leading Research In GI-Related…

Dr. Panaccione is the 2020 Crohn's Colitis Canada Outstanding Physician of the Year and is recognized as a 2020-23 Clarivate Research Scholar for being cited in the top 1% of researchers worldwide. He has co-authored over 350 manuscripts, 20 book chapters, and 625 abstracts, including publications in journals such as the New England Journal of Medicine, Lancet, JAMA, Nature, and Annals of Internal Medicine. Dr. Panaccione is the 2020 Crohn's Colitis Canada Outstanding Physician of the Year…
PR Newswire
13/10/2023

Santhera Receives Positive CHMP Opinion Recommending Approval of AGAMREE®…

Ad hoc announcement pursuant to Art. 53 LRCommittee for Medicinal Products for Human Use (CHMP) issues positive opinion for AGAMREE® (vamorolone) for the treatment Duchenne muscular dystrophy (DMD) in children and adults aged 4 years and olderEuropean Commission (EC) decision on marketing authorization is expected in late 2023AGAMREE could become the first drug fully approved by the European Medicines Agency (EMA) for the treatment of patients with DMD Anticipation of...
Nasdaq GlobeNewswire
13/10/2023

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion

Vueway® (Gadopiclenol), is a new macrocyclic gadolinium-based contrast agent (GBCA), very stable and with the highest relaxivity among all the other GBCAs on the market today1, so that its approved dose is exactly half of that approved for other macrocyclic GBCAs for similar indications2. It was approved by the United States Food and Drug Administration (US FDA) in September 2022. Vueway®(Gadopiclenol), is a new macrocyclic gadolinium-based contrast agent (GBCA), very stable and with the...
PR Newswire
13/10/2023

EADV Congress: Study reveals significant stigma associated with female adult…

The researchers tracked the eye movements of 245 participants who viewed neutral and emotional faces of females with both clear skin and clinically relevant anatomical variants of acne (emotions included 'happy', 'angry' and 'neutral'). Images were rated for acne-related visual disturbance while emotional faces were rated for valence intensity. Separately, a group of 205 online survey respondents were asked to rate the personality traits of the individuals depicted in the images. The...
PR Newswire
13/10/2023

Open-Angle Glaucoma Market Size and Share to Accelerate Substantially by 2032…

Key Takeaways from the Open-Angle Glaucoma Market Report Key Takeaways from the Open-Angle Glaucoma Market Report Discover which therapies are expected to grab the major open-angle glaucoma market share @Open-Angle Glaucoma Market Report Open-Angle Glaucoma Overview Open-angle glaucoma is a prevalent and serious ocular condition that impacts the optic nerve, potentially leading to vision impairment or blindness if left unattended. It stands as the most widespread type of...
PR Newswire
12/10/2023

Cellectis and Imagine Institute Publish A Proof-Of-Concept Study of a Gene…

Molecular Therapy – Methods & Clinical Development, demonstrating the efficacy of its TALEN-mediated gene correction of mutatedPIK3CDgene in APDS1 T-cells.The research work described in this article was jointly conducted by Imagine Institute and Cellectis teams.About APDS1:Activated phosphoinositide 3-kinase δ syndrome (also known as APDS type 1 or APDS1) is a rare but devastating disease caused by gain-of-function mutations in thePIK3CDgene and resulting in a combined...
Nasdaq GlobeNewswire
12/10/2023

NICO Awards $40,000 Grant to London's Kings College Hospital

Study investigators believe this kind of analysis can provide crucial information to current research in neuro-oncology. Dr. Bhangoo is Clinical Director of Neuroscience and Dr. Lavador a Consultant Neurosurgeon at King's College Hospital. They are seeking a better understanding of the impact NICO technologies have on patient recovery. Existing published data suggests that NICO technologies cause less damage to brain fiber tracts when accessing tumors in deep subcortical regions of the brain…
PR Newswire
12/10/2023

Pancreatitis Disease Market Insights: Epidemiology Study, Drug Development…

Price and Market Access Price and Market Access The Market Competitors Listed Below are Revolutionizing Healthcare with Innovative Diagnostic Inventions: Apart from that, hyperglycemia pancreatitis, gallstone pancreatitis, and alcoholic pancreatitis are some of the sub types of this severe ailment. Causes And Symptoms of This Ailment: There are numerous causes of pancreatitis including excessive alcohol intake, improper diet, trauma injuries to the pancreas, medicine side...
PR Newswire
12/10/2023

Reshaping Hepatitis A Market Growth: Drug Development, Epidemiology Study, Price…

As discussed, hepatitis is a virus triggered ailment and therefore is communicable in nature. Proper management of this ailment is crucial to prevent any sort of an outbreak. Hep a treatment and diagnostic solutions are being developed across the globe. Disease Landscape Insights has been helping players with Clinical trial feasibility analysis, clinical trial management, treatment gap identification, and product portfolio extension. It has also been offering them with pharma consulting…
PR Newswire
12/10/2023
Altri  Comunicati